Cargando…

Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice

Dysregulated glucagon drives hyperfunction in hepatic glucose output, which is the main cause of persistent hyperglycemia in type 2 diabetes. Berberine (Zhang et al., 2010) has been used as a hypoglycemic agent, yet the mechanism by which BBR inhibits hepatic gluconeogenesis remains incompletely und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Ying, Jin, Jing, Liu, Peiyu, Song, Yu, Zhang, Hui, Sheng, Liang, Zhou, Huifang, Jiang, Bijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961611/ https://www.ncbi.nlm.nih.gov/pubmed/31976031 http://dx.doi.org/10.1155/2020/6210526

Ejemplares similares

Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice
por: Li, Meng, et al.
Publicado: (2019)

Sitagliptin Improves Postprandial Hyperglycemia by Inhibiting Glucagon Secretion in Werner Syndrome With Diabetes
por: Watanabe, Kaneyuki, et al.
Publicado: (2013)

Berberine attenuates fructose-induced insulin resistance by stimulating the hepatic LKB1/AMPK/PGC1α pathway in mice
por: Li, Yucheng, et al.
Publicado: (2020)

Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
por: Cheng, Kai-Chun, et al.
Publicado: (2020)

Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE(-/-) mice by down-regulating PCSK9 via ERK1/2 pathway
por: Ma, Chun-Yan, et al.
Publicado: (2021)

Olfactory marker protein regulation of glucagon secretion in hyperglycemia
por: Oh, Ju Hun, et al.
Publicado: (2022)

Activation of intestinal olfactory receptor stimulates glucagon-like peptide-1 secretion in enteroendocrine cells and attenuates hyperglycemia in type 2 diabetic mice
por: Kim, Ki-Suk, et al.
Publicado: (2017)

Berberine attenuates sepsis-induced cardiac dysfunction by upregulating the Akt/eNOS pathway in mice
por: Zhang, Hong, et al.
Publicado: (2022)

Glucagon Like Peptide-1-Induced Glucose Metabolism in Differentiated Human Muscle Satellite Cells Is Attenuated by Hyperglycemia
por: Green, Charlotte J., et al.
Publicado: (2012)

Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice
por: Ma, Xiaomeng, et al.
Publicado: (2010)

Hepatic overexpression of protein targeting to glycogen attenuates obesity and improves hyperglycemia in db/db mice
por: López-Soldado, Iliana, et al.
Publicado: (2022)

Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
por: Deng, Yuanjun, et al.
Publicado: (2019)

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
por: Xia, Xuan, et al.
Publicado: (2011)

Berberine Inhibits MDA-MB-231 Cells by Attenuating Their Inflammatory Responses
por: Zhao, Lina, et al.
Publicado: (2020)

Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
por: Lee, Young-Sun, et al.
Publicado: (2016)

Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
por: Tan, Tricia M., et al.
Publicado: (2013)

BDNF Action in the Brain Attenuates Diabetic Hyperglycemia via Insulin-Independent Inhibition of Hepatic Glucose Production
por: Meek, Thomas H., et al.
Publicado: (2013)

Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals
por: Wang, Ying, et al.
Publicado: (2022)

NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action
por: Sheng, Liang, et al.
Publicado: (2012)

Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro
por: He, Qichen, et al.
Publicado: (2022)

Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice
por: Dkhil, Mohamed A
Publicado: (2014)

Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production
por: Knudsen, Jakob G., et al.
Publicado: (2019)

Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells
por: Zheng, Jingna, et al.
Publicado: (2023)

Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia: study protocol for a randomized controlled trial
por: Ming, Jie, et al.
Publicado: (2018)

Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis
por: Yang, Tao, et al.
Publicado: (2022)

Diallyl trisulfide attenuates hyperglycemia-induced endothelial apoptosis by inhibition of Drp1-mediated mitochondrial fission
por: Hao, Ying, et al.
Publicado: (2019)

FAM3C activates HSF1 to suppress hepatic gluconeogenesis and attenuate hyperglycemia of type 1 diabetic mice
por: Chen, Zhenzhen, et al.
Publicado: (2017)

Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats
por: Gong, Jing, et al.
Publicado: (2017)

Moderate Calorie Restriction Enhances Hepatic Glucagon Sensitivity in Aged Mice
por: Hutchison, Stephen, et al.
Publicado: (2021)

Glucagon like receptor 1/ glucagon dual agonist acutely enhanced hepatic lipid clearance and suppressed de novo lipogenesis in mice
por: More, Vijay R., et al.
Publicado: (2017)

Sodium Meta-Arsenite Ameliorates Hyperglycemia in Obese Diabetic db/db Mice by Inhibition of Hepatic Gluconeogenesis
por: Lee, Young-Sun, et al.
Publicado: (2014)

Myostatin inhibition improves hyperglycemia and hyperphagia in lipodystrophic mice
por: Guo, Tingqing, et al.
Publicado: (2012)

Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling
por: Zhang, Junfang, et al.
Publicado: (2013)

Intra-Herb Interactions: Primary Metabolites in Coptidis Rhizoma Extract Improved the Pharmacokinetics of Oral Berberine Hydrochloride in Mice
por: Zhao, Jing, et al.
Publicado: (2021)

Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats
por: Chen, Huiqi, et al.
Publicado: (2021)

Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis
por: Du, Yishan, et al.
Publicado: (2022)

Chlorogenic Acid Inhibits Ceramide Accumulation to Restrain Hepatic Glucagon Response
por: Xiao, Na, et al.
Publicado: (2023)

Protective effect of berberine chloride on Plasmodium chabaudi-induced hepatic tissue injury in mice
por: Dkhil, Mohamed A., et al.
Publicado: (2015)

Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway
por: Qian, Weichun, et al.
Publicado: (2018)

Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells
por: Wang, Ning, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0chebdechet1da4e02c4i4k5tu